Mc Adam, LLC Verastem, Inc. Transaction History

Mc Adam, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 24, 2023	BUY	$0.39 - $0.71 $508 - $925	1,304 Added 4.2%	32,358 $13,000
Q4 2022 Jan 27, 2023	SELL	$0.33 - $10.44 $429 - $13,603	-1,303 Reduced 4.03%	31,054 $64,000
Q3 2022 Oct 24, 2022	BUY	$0.92 - $11.16 $722 - $8,760	785 Added 2.49%	32,357 $28,000
Q2 2022 Jul 15, 2022	BUY	$1.02 - $1.83 $527 - $946	517 Added 1.66%	31,572 $37,000
Q1 2022 Apr 07, 2022	BUY	$1.06 - $2.1 $1 - $2	1 Added 0.0%	31,055 $44,000
Q1 2021 Apr 26, 2021	SELL	$1.9 - $2.82 $665 - $987	-350 Reduced 1.11%	31,054 $77,000
Q4 2020 Jan 12, 2021	SELL	$1.15 - $2.4 $1,724 - $3,600	-1,500 Reduced 4.56%	31,404 $74,000
Q3 2020 Nov 13, 2020	BUY	$1.11 - $1.68 $36,523 - $55,278	32,904 New	32,904 $40,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.09B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Mc Adam, LLC, based on Form 13F filings with the SEC.

Stay updated on Mc Adam, LLC with notifications on news.